381 related articles for article (PubMed ID: 17228487)
1. Statin therapy in cardiovascular diseases other than atherosclerosis.
Beaudry D; Stone KE; Wetherold S; Hemphill J; Do D; McClish J; Chilton R
Curr Atheroscler Rep; 2007 Jan; 9(1):25-32. PubMed ID: 17228487
[TBL] [Abstract][Full Text] [Related]
2. Effects of statin therapy on the progression of chronic kidney disease.
Shah S; Paparello J; Danesh FR
Adv Chronic Kidney Dis; 2005 Apr; 12(2):187-95. PubMed ID: 15822054
[TBL] [Abstract][Full Text] [Related]
3. Beyond lipid lowering: the role of statins in vascular protection.
Liao JK
Int J Cardiol; 2002 Nov; 86(1):5-18. PubMed ID: 12243846
[TBL] [Abstract][Full Text] [Related]
4. Effect of statins on toll-like receptors: a new insight to pleiotropic effects.
Bahrami A; Parsamanesh N; Atkin SL; Banach M; Sahebkar A
Pharmacol Res; 2018 Sep; 135():230-238. PubMed ID: 30120976
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
6. Statin therapy--Part II: Clinical considerations for cardiovascular disease.
Sadowitz B; Seymour K; Costanza MJ; Gahtan V
Vasc Endovascular Surg; 2010 Aug; 44(6):421-33. PubMed ID: 20547576
[TBL] [Abstract][Full Text] [Related]
7. Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease.
Sadowitz B; Maier KG; Gahtan V
Vasc Endovascular Surg; 2010 May; 44(4):241-51. PubMed ID: 20403949
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
Marzilli M
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
[TBL] [Abstract][Full Text] [Related]
9. [Statins and asthma].
Pawlak J; Ziętkowski Z; Bodzenta-Łukaszyk A
Postepy Hig Med Dosw (Online); 2011 Mar; 65():177-89. PubMed ID: 21502694
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs: Novel Molecular Targets and Response Modulators of Statin Therapy.
Mohajeri M; Banach M; Atkin SL; Butler AE; Ruscica M; Watts GF; Sahebkar A
Trends Pharmacol Sci; 2018 Nov; 39(11):967-981. PubMed ID: 30249403
[TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins.
Lahera V; Goicoechea M; de Vinuesa SG; Miana M; de las Heras N; Cachofeiro V; Luño J
Curr Med Chem; 2007; 14(2):243-8. PubMed ID: 17266583
[TBL] [Abstract][Full Text] [Related]
12. Statins: 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors demonstrate anti-atherosclerotic character due to their antioxidant capacity.
Puttananjaiah MK; Dhale MA; Gaonkar V; Keni S
Appl Biochem Biotechnol; 2011 Jan; 163(2):215-22. PubMed ID: 20640529
[TBL] [Abstract][Full Text] [Related]
13. Defining the role of high-dose statins in PCI.
Guarini G; Marzilli M
Am J Cardiovasc Drugs; 2013 Jun; 13(3):189-97. PubMed ID: 23589336
[TBL] [Abstract][Full Text] [Related]
14. Statin therapy-evidence beyond lipid lowering contributing to plaque stability.
de Lorenzo F; Feher M; Martin J; Collot-Teixeira S; Dotsenko O; McGregor JL
Curr Med Chem; 2006; 13(28):3385-93. PubMed ID: 17168712
[TBL] [Abstract][Full Text] [Related]
15. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
16. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy.
Zhou Q; Liao JK
Curr Pharm Des; 2009; 15(5):467-78. PubMed ID: 19199975
[TBL] [Abstract][Full Text] [Related]
17. Statins and biomarkers of inflammation.
Devaraj S; Rogers J; Jialal I
Curr Atheroscler Rep; 2007 Jan; 9(1):33-41. PubMed ID: 17169243
[TBL] [Abstract][Full Text] [Related]
18. Does it matter whether or not a lipid-lowering agent inhibits Rho kinase?
Liao JK
Curr Atheroscler Rep; 2007 Nov; 9(5):384-8. PubMed ID: 18001621
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic Benefits of Statins in Cardiovascular Diseases.
Wasim R; Ansari TM; Ahsan F; Siddiqui MH; Singh A; Shariq M; Parveen S
Drug Res (Stuttg); 2022 Nov; 72(9):477-486. PubMed ID: 35868336
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.
Wang CY; Liu PY; Liao JK
Trends Mol Med; 2008 Jan; 14(1):37-44. PubMed ID: 18068482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
